Trending...
- Green Energy Solar Expands with New Offices in Port St. Lucie, West Palm Beach, and Orlando
- New Book 'Cybersecurity Leadership' Guides SME Leaders to Make Smart, Strategic Security Decisions
- Austin Keen Joins WakeFX RopePal as Official Brand Ambassador
FAYETTEVILLE, Ark. - PrAtlas -- Lineus Medical continues to expand its distribution network for SafeBreak® Vascular. This time, it's in the veterinary space, with SafeBreak® Vascular Vet. Lineus has signed an exclusive, global, private-label agreement with a global, animal-health technology and services company dedicated to supporting the companion, equine, and large-animal veterinary markets. The global distribution partner has a presence in 19 countries servicing over 100,000 customers worldwide positioning them to deliver exceptional care to their patients when and where it is needed.
SafeBreak Vascular Vet is a first of its kind breakaway device designed to remove harmful forces from peripheral IV lines by intentionally separating when damaging levels of force are applied to the IV line. By preventing harmful IV line forces from reaching the animal's catheter, SafeBreak Vascular Vet reduces IV complications requiring an IV restart. 1,2 When SafeBreak separates, a new, sterile SafeBreak can be placed in the line, and the animal's infusion restarted without the need for additional needlesticks, wasted supplies and wasted time for the veterinary practice.
More on PrAtlas
A randomized controlled trial with 367 dogs was published in the Journal of American Veterinary Medical Association (JAVMA) and completed at Colorado State University in 2022. The results of this study concluded that SafeBreak significantly reduced IV complications by 65%.1
Vance Clement, CEO of Lineus Medical, said, "The partnership with this large global distributor is an incredible step forward in our efforts to make SafeBreak the standard in IV care for both human and animal patients. We are proud to be working with a global, veterinary medical product distributor, and we believe that this partnership will bring SafeBreak's break-away technology to the veterinary space much faster than we could have accomplished on our own."
ABOUT LINEUS MEDICAL
Lineus Medical is the developer of vascular access products that are designed to improve the patient experience, make healthcare workers' jobs easier and lower the overall cost of healthcare. Learn more at www.lineusmed.com and follow us on LinkedIn or Twitter.
1. Colorado State University Study Data on File
2. University of Tennessee Large Animal Study Data on File
MKG-0190 REV 00
SafeBreak Vascular Vet is a first of its kind breakaway device designed to remove harmful forces from peripheral IV lines by intentionally separating when damaging levels of force are applied to the IV line. By preventing harmful IV line forces from reaching the animal's catheter, SafeBreak Vascular Vet reduces IV complications requiring an IV restart. 1,2 When SafeBreak separates, a new, sterile SafeBreak can be placed in the line, and the animal's infusion restarted without the need for additional needlesticks, wasted supplies and wasted time for the veterinary practice.
More on PrAtlas
- Aureli Construction Sets the Standard for Seamless Home Additions in Greater Boston
- ScreenPoints Puts Film Investors in the Credits—and in the Money With New FinTech Platform
- Pathways to Adulthood Conference May 17 at Melville Marriott Honoring NYS Assembly Member Jodi Giglio, Suffolk County Legislator Nick Caracappa
- Adster Techologies awarded US Patent for breakthrough innovation in reducing latency in Ad Serving
- Robert Fabbio Inducted into the Austin Technology Council Hall of Fame
A randomized controlled trial with 367 dogs was published in the Journal of American Veterinary Medical Association (JAVMA) and completed at Colorado State University in 2022. The results of this study concluded that SafeBreak significantly reduced IV complications by 65%.1
Vance Clement, CEO of Lineus Medical, said, "The partnership with this large global distributor is an incredible step forward in our efforts to make SafeBreak the standard in IV care for both human and animal patients. We are proud to be working with a global, veterinary medical product distributor, and we believe that this partnership will bring SafeBreak's break-away technology to the veterinary space much faster than we could have accomplished on our own."
ABOUT LINEUS MEDICAL
Lineus Medical is the developer of vascular access products that are designed to improve the patient experience, make healthcare workers' jobs easier and lower the overall cost of healthcare. Learn more at www.lineusmed.com and follow us on LinkedIn or Twitter.
1. Colorado State University Study Data on File
2. University of Tennessee Large Animal Study Data on File
MKG-0190 REV 00
Source: Lineus Medical
0 Comments
Latest on PrAtlas
- $56.7 Million Announced in Q1 2025 with Revenue Growth and Progress Toward NASDAQ Uplisting for AI Marketing Company: IQSTEL, Inc. Stock Symbol: IQSTD
- SAVVY MINING raised $500 million and launched BTC.XRP.DOGE cloud mining, increasing investors' returns by 30%
- New National Nonprofit Launches to Capture Firsthand Accounts of Adoption Stories
- The Tide Project Opens at Biennale Architettura 2025 in Venice Amplifying Youth Voices
- Wall Street analysts say BTC.XRP.DOGE cloud mining company SIX MINING is expected to achieve a 5-fold increase, allowing users to easily mine BTC
- Gen X Takes The Reins: New Book Guides Caregivers Juggling Parents, Kids, And Grandkids With Humor And Heart
- Fray Fitness Launches Memorial Day Sale and Veteran Organization Giveaway
- ABM for Good™ Launches First Project with Build Change
- ImagineX, in Collaboration with Qualys, Launches New mROC Services to Transform Enterprise Cyber Risk Management
- Ditch Micromanagement: New Leadership Book for Results-Driven, Accountability-Based Teams
- Jay Tapp was named Managing Director in British Columbia
- Hubei Heavy Equipment Makes a Striking Appearance at CIMT and Competes with International Brands
- 20 Patents Issued Worldwide, Cementing Company Leadership. First Ever Cable-Free 12-Lead ECG: HeartBeam, Inc. (Stock Symbol: BEAT)
- NASDAQ Uplisting for Higher Market Exposure and Wide Corporate Benefits to AI Boosted Marketing Company On Track Towards $1 Billion Revenue by 2027
- Congressional Men's Health Caucus Shows Bipartisan Consensus and Focus on Prevention, Mental Health, and Closing the Lifespan Gap
- DuoKey, Axiomtek and Blue Edge Network Partner to Enhance Smart Cities with Privacy-Preserving Urban Safeguarding and Fleet Management
- Austin Keen Joins WakeFX RopePal as Official Brand Ambassador
- Bonelli Systems Expands Managed IT Services Nationwide, Leveraging Microsoft Azure Expertise
- $4.3 Million Patent Application Waiver Fee Granted by FDA on New Drug Application Fee for Treatment Addressing Suicidal Depression & PTSD: NRX Pharma
- Whistleblower Claims Dental Patient Deaths Likely Due to Book Ban